Fig. 6

The functional and pathway enrichment from PAH patients with high TFRC and diagnostic power of TFRC. (A) The GSEA analysis showing biological processes enriched in high TFRC group versus low TFRC group in training dataset. (B) The KEGG analysis displaying biological pathways enriched in high TFRC group versus low TFRC group in training dataset. (C) The ROC curve of validation cohort in dataset GSE53408, (D) The ROC curve of validation cohort in dataset GSE22356.